News
Tuesday, June 24th, 2014
JAMA: June 11, 2014 Importance Preferred second-line medication for diabetes treatment after metformin failure remains uncertain. Objective To compare time to acute myocardial infarction (AMI), stroke, or death in a cohort of metformin initiators who added insulin or a sulfonylurea. Design, Setting, and Participants Retrospective cohort constructed with national Veterans Health Administration, Medicare, and National Death Index databases. The study […]
News
Tuesday, June 24th, 2014
JAMA: June 11, 2014 Importance The incidence and prevalence of type 2 diabetes mellitus are increasing. Objective To review currently available insulin therapy, as well as evidence on the use, application, initiation, and intensification of insulin in the outpatient setting. Evidence Review Data sources included PubMed for trials and investigations in type 2 diabetes examining insulin use from January 1998 to […]
News
Tuesday, June 24th, 2014
CDC: Tuesday, June 10, 2014 Prevention efforts crucial to combat serious health risks People with diabetes often use a blood glucose monitoring device to help them maintain healthy glucose levels. More than 29 million people in the United States have diabetes, up from the previous estimate of 26 million in 2010, according to a report […]
News
Tuesday, June 24th, 2014
Springer: May 2014 Aims/hypothesis A previous pooled analysis suggested that women with diabetes are at substantially increased risk of fatal CHD compared with affected men. Additional findings from several larger and more contemporary studies have since been published on the sex-specific associations between diabetes and incident CHD. We performed an updated systematic review with meta-analysis to […]
News
Tuesday, June 24th, 2014
Diabetes Spectrum May 2014 The American Diabetes Association (ADA) has long recognized the integral role of nutrition therapy in overall diabetes management and recommends that each person with diabetes receive an individualized eating plan that has been developed in collaboration with his or her health care provider (HCP).1 To ensure that members of the health care team […]
Minority Diabetes Reports
Tuesday, June 24th, 2014
JAMA: June 11, 2014 Importance Latino populations have one of the highest prevalences of type 2 diabetes worldwide. Objectives To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. Design, Setting, and Participants Whole-exome sequencing was performed on DNA […]
Minority Diabetes Reports
Tuesday, June 24th, 2014
Diabetes Spectrum: May 2014 Objective. The purpose of this study is to describe the impact of depression on perceptions of risks to health, diabetes self-management practices, and glycemic control in older African Americans with type 2 diabetes. Methods. The authors analyzed data on depression, risk perceptions, diabetes self-management, and A1C in African Americans with type 2 diabetes. T-tests, χ2, […]
Minority Diabetes Reports
Tuesday, June 24th, 2014
Diabetes Care May 1, 2014 OBJECTIVE To assess the relationship of depressive symptoms and use of antidepressants with incident type 2 diabetes in prospective data from a large cohort of U.S. African American women. RESEARCH DESIGN AND METHODS The Black Women’s Health Study (BWHS) is an ongoing prospective cohort study. We followed 35,898 women from 1999 through 2011 […]
Clinical Trial News
Tuesday, June 24th, 2014
Diabetes Care June 4, 2014 OBJECTIVE Depression is a common comorbidity of diabetes, undesirably affecting patients’ physical and mental functioning. Psychological interventions are effective treatments for depression in the general population as well as in patients with a chronic disease. The aim of this study was to assess the efficacy of individual mindfulness-based cognitive therapy (MBCT) and […]
Clinical Trial News
Tuesday, June 24th, 2014
Diabetes Care: June 4, 2014 OBJECTIVE GLP-1 receptor agonists may provide an alternative to prandial insulin for advancing basal insulin therapy. Harmony 6 was a randomized, open-label, active-controlled trial testing once-weekly albiglutide vs thrice-daily prandial insulin lispro as an add-on to titrated once-daily insulin glargine. RESEARCH DESIGN AND METHODS Patients taking basal insulin (with or without oral agents) […]
